InvestorsHub Logo
Followers 35
Posts 4673
Boards Moderated 0
Alias Born 12/14/2013

Re: Sam81 post# 66434

Friday, 12/11/2015 8:29:10 AM

Friday, December 11, 2015 8:29:10 AM

Post# of 426487
Thank You Sam


Looks like Vascepa sales increased almost as much as Generic Lovaza sales did.

As long as Vascepa sales quickly get to the point Amarin starts making money instead of losing money, I guess it doesn't matter than Generic Lovaza sales are climbing the same or better rate.

But over time, the Obamacare-favored generic may win out.





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News